Literature DB >> 17166316

Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study.

Leigh J Beglinger1, Kevin Duff, Sara Van Der Heiden, David J Moser, John D Bayless, Jane S Paulsen, Roger Gingrich.   

Abstract

The current study characterizes cognitive and psychiatric status in hematopoietic stem cell transplantation (HSCT) patients shortly before and after transplant. Thirty adult patients were assessed prospectively 1-2 weeks before transplantation and 100 days posttransplantation on neuropsychological and psychiatric measures. Before transplant, participants showed mild impairments on several neuropsychological measures, with the poorest performances occurring on learning and attention. Psychiatric functioning was significantly elevated compared with normative data. Significant improvements, however, were observed on neuropsychological measures by 100 days after transplant. Depression and anxiety scores also improved. Candidates for HSCT experienced mild diffuse cognitive dysfunction and psychiatric morbidity before the procedure, but these symptoms significantly improved by 3 months following their transplant in this small sample. Education about these possible pretransplant sequelae and the potential for rebound may be helpful to patients and families as they prepare for this treatment and the recovery period.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17166316     DOI: 10.1017/S1355617707070208

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  18 in total

1.  Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation.

Authors:  Heather S L Jim; Brent Small; Sheri Hartman; Jamie Franzen; Shannon Millay; Kristin Phillips; Paul B Jacobsen; Margaret Booth-Jones; Joseph Pidala
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

2.  The neuropsychological course of acute delirium in adult hematopoietic stem cell transplantation patients.

Authors:  Leigh J Beglinger; James A Mills; Stacie M Vik; Kevin Duff; Natalie L Denburg; Michelle T Weckmann; Jane S Paulsen; Roger Gingrich
Journal:  Arch Clin Neuropsychol       Date:  2010-12-23       Impact factor: 2.813

Review 3.  Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature.

Authors:  Catherine E Mosher; William H Redd; Christine M Rini; Jack E Burkhalter; Katherine N DuHamel
Journal:  Psychooncology       Date:  2009-02       Impact factor: 3.894

Review 4.  Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.

Authors:  Mackenzi Pergolotti; Nicolò Matteo Luca Battisti; Lynne Padgett; Alix G Sleight; Maya Abdallah; Robin Newman; Kathleen Van Dyk; Kelley R Covington; Grant R Williams; Frederiek van den Bos; YaoYao Pollock; Elizabeth A Salerno; Allison Magnuson; Isabella F Gattás-Vernaglia; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2019-10-14       Impact factor: 3.599

5.  Pretransplantation Cognitive Dysfunction in Advanced-Age Hematologic Cancers: Predictors and Associated Outcomes.

Authors:  James C Root; Claudine Campbell; Xiomara Rocha-Cadman; Nicole Kasven-Gonzalez; Molly Maloy; Jessica Flynn; Sean M Devlin; Ann A Jakubowski
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-21       Impact factor: 5.742

6.  Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation.

Authors:  Samantha J Mayo; Hans A Messner; Sean B Rourke; Doris Howell; J Charles Victor; Jeffrey H Lipton; J Kuruvilla; Vikas Gutpa; Dennis Dong Hwan Kim; Fotios V Michelis; Kelly Metcalfe
Journal:  Bone Marrow Transplant       Date:  2019-11-19       Impact factor: 5.483

7.  Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients.

Authors:  Heather Sl Jim; Tim D Boyd; Margaret Booth-Jones; Joseph Pidala; Huntington Potter
Journal:  Brain Disord Ther       Date:  2012

8.  Late cognitive outcomes among allogeneic stem cell transplant survivors: follow-up data from a 6-year longitudinal study.

Authors:  Samantha J Mayo; Isabel Wozniczka; Sarah Brennenstuhl; Sean B Rourke; Doris Howell; Kelly A Metcalfe; Jeffrey H Lipton
Journal:  Support Care Cancer       Date:  2020-09-23       Impact factor: 3.603

9.  Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndrome.

Authors:  Mary-Ellen Meadows; Grace Chang; Jennifer A Jones; Joseph R Antin; E John Orav
Journal:  Arch Clin Neuropsychol       Date:  2013-02-07       Impact factor: 2.813

10.  Risk factors for delirium in patients undergoing hematopoietic stem cell transplantation.

Authors:  Michelle T Weckmann; Roger Gingrich; James A Mills; Larry Hook; Leigh J Beglinger
Journal:  Ann Clin Psychiatry       Date:  2012-08       Impact factor: 1.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.